» Articles » PMID: 37998361

The Inflammasome-Dependent Dysfunction and Death of Retinal Ganglion Cells After Repetitive Intraocular Pressure Spikes

Abstract

The dysfunction and selective loss of retinal ganglion cells (RGCs) is a known cause of vision loss in glaucoma and other neuropathies, where ocular hypertension (OHT) is the major risk factor. We investigated the impact of transient non-ischemic OHT spikes (spOHT) on RGC function and viability in vivo to identify cellular pathways linking low-grade repetitive mechanical stress to RGC pathology. We found that repetitive spOHT had an unexpectedly high impact on intraocular homeostasis and RGC viability, while exposure to steady OHT (stOHT) of a similar intensity and duration failed to induce pathology. The repetitive spOHT induced the rapid activation of the inflammasome, marked by the upregulation of NLRP1, NLRP3, AIM2, caspases -1, -3/7, -8, and Gasdermin D (GSDMD), and the release of interleukin-1β (IL-1β) and other cytokines into the vitreous. Similar effects were also detected after 5 weeks of exposure to chronic OHT in an induced glaucoma model. The onset of these immune responses in both spOHT and glaucoma models preceded a 50% deficit in pattern electroretinogram (PERG) amplitude and a significant loss of RGCs 7 days post-injury. The inactivation of inflammasome complexes in , , and knockout animals significantly suppressed the spOHT-induced inflammatory response and protected RGCs. Our results demonstrate that mechanical stress produced by acute repetitive spOHT or chronic OHT is mechanistically linked to inflammasome activation, which leads to RGC dysfunction and death.

Citing Articles

NLRX1 limits inflammatory neurodegeneration in the anterior visual pathway.

Gill A, Smith M, Galleguillos D, Garton T, Mace J, Gadani S J Neuroinflammation. 2025; 22(1):21.

PMID: 39875919 PMC: 11773851. DOI: 10.1186/s12974-025-03339-0.


Corneal application of SOCS1/3 peptides for the treatment of eye diseases mediated by inflammation and oxidative stress.

Ahmed C, Johnson H, Lewin A Front Immunol. 2024; 15:1416181.

PMID: 39104531 PMC: 11298391. DOI: 10.3389/fimmu.2024.1416181.

References
1.
Rogers C, Alnemri E . Gasdermins: novel mitochondrial pore-forming proteins. Mol Cell Oncol. 2019; 6(5):e1621501. PMC: 6736162. DOI: 10.1080/23723556.2019.1621501. View

2.
Krishnan A, Kocab A, Zacks D, Marshak-Rothstein A, Gregory-Ksander M . A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma. J Neuroinflammation. 2019; 16(1):184. PMC: 6767653. DOI: 10.1186/s12974-019-1576-3. View

3.
Osborne N, Ugarte M, Chao M, Chidlow G, Bae J, Wood J . Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol. 1999; 43 Suppl 1:S102-28. DOI: 10.1016/s0039-6257(99)00044-2. View

4.
Jakobs C, Perner S, Hornung V . AIM2 Drives Joint Inflammation in a Self-DNA Triggered Model of Chronic Polyarthritis. PLoS One. 2015; 10(6):e0131702. PMC: 4482750. DOI: 10.1371/journal.pone.0131702. View

5.
Chou T, Romano G, Amato R, Porciatti V . Nicotinamide-Rich Diet in DBA/2J Mice Preserves Retinal Ganglion Cell Metabolic Function as Assessed by PERG Adaptation to Flicker. Nutrients. 2020; 12(7). PMC: 7401244. DOI: 10.3390/nu12071910. View